Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
7.01
-0.13 (-1.82%)
Sep 23, 2026, 3:04 PM CST

SHE:002566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
86.1663.5571.48487.73343.26219.7
Short-Term Investments
-----30.08
Trading Asset Securities
538.4507.57459.67102.9859.8470.16
Cash & Short-Term Investments
624.56571.13531.15590.72403.11319.94
Cash Growth
12.23%7.53%-10.08%46.54%25.99%11.48%
Accounts Receivable
213.74214.89199.03198.53264254.84
Other Receivables
19.1414.7610.5311.7522.2339.61
Receivables
232.88230.96209.56210.28286.23294.45
Inventory
1,5721,5811,6261,6171,6031,597
Other Current Assets
19.4614.78.5813.3210.1710.53
Total Current Assets
2,4492,3982,3762,4312,3032,222
Property, Plant & Equipment
401.55417.13450.34483.66526.11501.49
Long-Term Investments
15.7915.615.23---
Goodwill
1.911.911.911.911.911.91
Other Intangible Assets
107.32108.66111.35114.18117.03119.96
Long-Term Deferred Tax Assets
16.9815.8513.1512.6214.215.2
Long-Term Deferred Charges
1.221.542.152.023.072.99
Other Long-Term Assets
0.771.130.761.271.681.04
Total Assets
2,9942,9602,9713,0472,9672,864

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
13.5611.691324.8624.3319.81
Accrued Expenses
24.5122.4122.2632.5130.6848.11
Short-Term Debt
345.62308.23290.28470.43430.43397.86
Current Portion of Long-Term Debt
0.290.30.42--2.55
Current Portion of Leases
3.172.42.982.343.293.31
Current Income Taxes Payable
1.870.140.012.780.645.55
Current Unearned Revenue
9.8214.775.4911.0124.5116.72
Other Current Liabilities
23.3424.1731.5545.9174.2939.84
Total Current Liabilities
422.17384.1366589.85588.16533.75
Long-Term Debt
129.6129.7149.7---
Long-Term Leases
4.255.346.214.039.8211.46
Long-Term Unearned Revenue
105.19108.87112.54118.69118.02120.85
Long-Term Deferred Tax Liabilities
2.362.342.771.741.170.02
Total Liabilities
663.56630.35637.22714.3717.18666.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
330.95330.95330.95330.95330.95330.95
Additional Paid-In Capital
834.69834.69834.69834.69834.69834.69
Retained Earnings
1,0661,0661,0701,068989.34916.17
Total Common Equity
2,2322,2322,2362,2332,1552,082
Minority Interest
98.7697.7697.8399.2694.45116.47
Shareholders' Equity
2,3312,3292,3332,3322,2492,198
Total Liabilities & Equity
2,9942,9602,9713,0472,9672,864

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
482.92445.97449.59476.8443.55415.18
Net Cash (Debt)
141.63125.1681.56113.92-40.44-95.24
Net Cash Growth
106.53%53.45%-28.40%---
Net Cash Per Share
0.430.380.250.34-0.12-0.29
Filing Date Shares Outstanding
330.95330.95330.95330.95330.95330.95
Total Common Shares Outstanding
330.95330.95330.95330.95330.95330.95
Working Capital
2,0262,0142,0101,8411,7141,688
Book Value Per Share
6.746.746.766.756.516.29
Tangible Book Value
2,1232,1212,1222,1172,0361,960
Tangible Book Value Per Share
6.416.416.416.406.155.92
Buildings
548.36548.36548.14548.14545.7400.71
Machinery
351.27352.2353.49359357.13321.57
Construction In Progress
----1.98119.32